Methyl (1S,3R,4R)-2-azabicyclo[2.2.1]heptane-3-carboxylate, 97%, 250mg

(4-Aminophenyl)piperidin-1-ylmethanone, 95.0%, 5g

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propane-1-sulfonamide, 95%, 100mg

ethyl 7-(4-bromo-2-methylphenyl)-7-oxoheptanoate, 97.0%, 2g

Methyl 2-bromo-3-fluorobenzoate, 98.0%, 5g

2-Fluoro-4,5-dimethoxybenzoic acid, 95.0%, 10g

3-(4-(Hydroxymethyl)phenyl)propanoic acid, 95+%, 5g

4-Cyclohexylbutan-1-ol, 95%, 100mg

(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid, 98.0%, 1g

(4-((Furan-2-ylmethoxy)methyl)phenyl)boronic acid, 95.0%, 5g

(3R)-3-dodecanoyloxy-4-trimethylammonio-butanoate, 25mg

2-Phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylic acid, 97%, 250mg

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 2.00 µm, 1 Piece(s)